Egr-1 is a Major Vascular Pathogenic Transcription Factor in Atherosclerosis and Restenosis
Authors:
- 1 August 2004
- journal article
- review article
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 5 (3) , 249-254
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Differential Regulation of Early Growth Response Gene-1 Expression by Insulin and Glucose in Vascular Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Inflammation in atherosclerosisNature, 2002
- Vascular Smooth Muscle Cells Express the Transcriptional Corepressor NAB2 in Response to InjuryThe American Journal of Pathology, 1999
- NAB2: A Transcriptional Brake for Activated Gene Expression in the Vessel Wall?The American Journal of Pathology, 1999
- Vascular Smooth Muscle Cell Proliferation and Regrowth after Mechanical Injury in Vitro Are. Egr-1/NGFI-A-DependentThe American Journal of Pathology, 1999
- Monocyte Chemoattractant Protein-1 Expression in Aortic Tissues of Hypertensive RatsHypertension, 1997
- A Regulatory Element in the Human Interleukin 2 Gene Promoter Is a Binding Site for the Zinc Finger Proteins Sp1 and EGR-1Journal of Biological Chemistry, 1995
- Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle cellsAtherosclerosis, 1993
- Pharmacology of smooth muscle cell replication.Hypertension, 1992
- Left main coronary artery stenosis as a late complication of percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1987